EE04023B1
(et)
|
1996-10-18 |
2003-04-15 |
Vertex Pharmaceuticals Incorporated |
Seriinproteaaside, eriti C-hepatiidi viiruse NS3-proteaasi inhibiitorid
|
US6608027B1
(en)
|
1999-04-06 |
2003-08-19 |
Boehringer Ingelheim (Canada) Ltd |
Macrocyclic peptides active against the hepatitis C virus
|
US7244721B2
(en)
*
|
2000-07-21 |
2007-07-17 |
Schering Corporation |
Peptides as NS3-serine protease inhibitors of hepatitis C virus
|
SV2003000617A
(es)
|
2000-08-31 |
2003-01-13 |
Lilly Co Eli |
Inhibidores de la proteasa peptidomimetica ref. x-14912m
|
US7119072B2
(en)
|
2002-01-30 |
2006-10-10 |
Boehringer Ingelheim (Canada) Ltd. |
Macrocyclic peptides active against the hepatitis C virus
|
US6642204B2
(en)
|
2002-02-01 |
2003-11-04 |
Boehringer Ingelheim International Gmbh |
Hepatitis C inhibitor tri-peptides
|
US7091184B2
(en)
|
2002-02-01 |
2006-08-15 |
Boehringer Ingelheim International Gmbh |
Hepatitis C inhibitor tri-peptides
|
DE60336986D1
(de)
|
2002-03-05 |
2011-06-16 |
Sumitomo Chemical Co |
Verfahren zur herstellung von biarylverbindungen
|
CN100381440C
(zh)
|
2002-04-11 |
2008-04-16 |
沃泰克斯药物股份有限公司 |
丝氨酸蛋白酶、特别是丙型肝炎病毒ns3-ns4蛋白酶的抑制剂
|
US20050075279A1
(en)
|
2002-10-25 |
2005-04-07 |
Boehringer Ingelheim International Gmbh |
Macrocyclic peptides active against the hepatitis C virus
|
PE20050204A1
(es)
|
2003-05-21 |
2005-05-04 |
Boehringer Ingelheim Int |
Compuestos inhibidores de la hepatitis c
|
DE602004025569D1
(de)
|
2003-06-18 |
2010-04-01 |
Tranzyme Pharma Inc |
Makrozyklische motilin rezeptorantagonisten
|
EP1664090A2
(en)
|
2003-08-26 |
2006-06-07 |
Schering Corporation |
Novel peptidomimetic ns3-serine protease inhibitors of hepatitis c virus
|
UY28500A1
(es)
|
2003-09-05 |
2005-04-29 |
Vertex Pharma |
Inhibidores de proteasas de serina, en particular proteasa ns3-ns4a del vhc.
|
CA2536182C
(en)
|
2003-09-22 |
2012-07-24 |
Boehringer Ingelheim International Gmbh |
Macrocyclic peptides active against the hepatitis c virus
|
TWI280964B
(en)
*
|
2003-09-26 |
2007-05-11 |
Schering Corp |
Macrocyclic inhibitors of hepatitis C virus NS3 serine protease
|
RU2006115558A
(ru)
|
2003-10-10 |
2007-11-20 |
Вертекс Фармасьютикалз Инкорпорейтед (Us) |
Ингибиторы сериновых протеаз, особенно hcv ns3-ns4a протеазы
|
US7491794B2
(en)
*
|
2003-10-14 |
2009-02-17 |
Intermune, Inc. |
Macrocyclic compounds as inhibitors of viral replication
|
EP1944042A1
(en)
|
2003-10-27 |
2008-07-16 |
Vertex Pharmceuticals Incorporated |
Combinations for HCV treatment
|
US8187874B2
(en)
|
2003-10-27 |
2012-05-29 |
Vertex Pharmaceuticals Incorporated |
Drug discovery method
|
CN1902216A
(zh)
|
2003-11-20 |
2007-01-24 |
先灵公司 |
丙肝病毒ns3蛋白酶的去肽化抑制剂
|
EP1730167B1
(en)
|
2004-01-21 |
2011-01-12 |
Boehringer Ingelheim International GmbH |
Macrocyclic peptides active against the hepatitis c virus
|
EP1713822B1
(en)
*
|
2004-01-30 |
2010-03-17 |
Medivir AB |
Hcv ns-3 serine protease inhibitors
|
US7683033B2
(en)
|
2004-02-04 |
2010-03-23 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
|
PT1719773E
(pt)
|
2004-02-24 |
2009-06-03 |
Japan Tobacco Inc |
Compostos heterotetracíclicos fundidos e a sua utilização como inibidores da polimerase do hcv
|
US20070049593A1
(en)
|
2004-02-24 |
2007-03-01 |
Japan Tobacco Inc. |
Tetracyclic fused heterocyclic compound and use thereof as HCV polymerase inhibitor
|
ATE438622T1
(de)
|
2004-02-27 |
2009-08-15 |
Schering Corp |
3,4-(cyclopentyl)kondensierte prolinverbindungen als inhibitoren der ns3-serinprotease des hepatitis-c-virus
|
US7205330B2
(en)
|
2004-02-27 |
2007-04-17 |
Schering Corporation |
Inhibitors of hepatitis C virus NS3 protease
|
JP2007525510A
(ja)
|
2004-02-27 |
2007-09-06 |
シェーリング コーポレイション |
C型肝炎ウイルスns3セリンプロテアーゼのインヒビターとしての化合物
|
DE602005021760D1
(de)
|
2004-02-27 |
2010-07-22 |
Schering Corp |
Schwefelverbindungen als inhibitoren der ns3-serinprotease des hepatitis-c-virus
|
DE602005015093D1
(de)
|
2004-02-27 |
2009-08-06 |
Schering Corp |
Neue verbindungen als inhibitoren der ns3-serinprotease des hepatitis-c-virus
|
US7816326B2
(en)
|
2004-02-27 |
2010-10-19 |
Schering Corporation |
Sulfur compounds as inhibitors of hepatitis C virus NS3 serine protease
|
WO2005113581A1
(en)
|
2004-05-20 |
2005-12-01 |
Schering Corporation |
Substituted prolines as inhibitors of hepatitis c virus ns3 serine protease
|
JP2005350417A
(ja)
*
|
2004-06-11 |
2005-12-22 |
Dai Ichi Seiyaku Co Ltd |
還元的エーテル化法を用いたピロリジン誘導体の製造法
|
ATE512971T1
(de)
|
2004-07-20 |
2011-07-15 |
Boehringer Ingelheim Int |
Peptidanaloga als hepatitis c-hemmer
|
UY29016A1
(es)
|
2004-07-20 |
2006-02-24 |
Boehringer Ingelheim Int |
Analogos de dipeptidos inhibidores de la hepatitis c
|
CN101068828A
(zh)
|
2004-08-27 |
2007-11-07 |
先灵公司 |
用作丙型肝炎病毒ns3丝氨酸蛋白酶抑制剂的酰基磺酰胺化合物
|
WO2007001406A2
(en)
*
|
2004-10-05 |
2007-01-04 |
Chiron Corporation |
Aryl-containing macrocyclic compounds
|
US7659263B2
(en)
|
2004-11-12 |
2010-02-09 |
Japan Tobacco Inc. |
Thienopyrrole compound and use thereof as HCV polymerase inhibitor
|
AU2006242475B2
(en)
*
|
2005-05-02 |
2011-07-07 |
Merck Sharp & Dohme Corp. |
HCV NS3 protease inhibitors
|
JP5160415B2
(ja)
*
|
2005-06-02 |
2013-03-13 |
メルク・シャープ・アンド・ドーム・コーポレーション |
医薬処方物およびそれを用いる治療方法
|
US20110104109A1
(en)
*
|
2005-07-13 |
2011-05-05 |
Frank Bennett |
Tetracyclic indole derivatives and their use for treating or preventing viral infections
|
AR057456A1
(es)
|
2005-07-20 |
2007-12-05 |
Merck & Co Inc |
Inhibidores de la proteasa ns3 del vhc
|
JP5249028B2
(ja)
|
2005-07-25 |
2013-07-31 |
インターミューン・インコーポレーテッド |
C型肝炎ウイルス複製の新規大環状阻害剤
|
MX2008001588A
(es)
*
|
2005-08-01 |
2008-02-19 |
Merck & Co Inc |
Inhibidores de proteasa ns3 del vhc.
|
EP2402331A1
(en)
*
|
2005-08-02 |
2012-01-04 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of serine proteases
|
US8399615B2
(en)
|
2005-08-19 |
2013-03-19 |
Vertex Pharmaceuticals Incorporated |
Processes and intermediates
|
EP2357170A1
(en)
|
2005-08-19 |
2011-08-17 |
Vertex Pharmaceuticals Incorporated |
Processes and intermediates
|
US7964624B1
(en)
|
2005-08-26 |
2011-06-21 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of serine proteases
|
AR055395A1
(es)
|
2005-08-26 |
2007-08-22 |
Vertex Pharma |
Compuestos inhibidores de la actividad de la serina proteasa ns3-ns4a del virus de la hepatitis c
|
DE602006019323D1
(de)
|
2005-10-11 |
2011-02-10 |
Intermune Inc |
Verbindungen und verfahren zur inhibierung der replikation des hepatitis-c-virus
|
KR20080072906A
(ko)
|
2005-11-11 |
2008-08-07 |
버텍스 파마슈티칼스 인코포레이티드 |
C형 간염 바이러스 변이체
|
US7705138B2
(en)
|
2005-11-11 |
2010-04-27 |
Vertex Pharmaceuticals Incorporated |
Hepatitis C virus variants
|
US7816348B2
(en)
|
2006-02-03 |
2010-10-19 |
Boehringer Ingelheim International Gmbh |
Viral polymerase inhibitors
|
WO2007098270A2
(en)
|
2006-02-27 |
2007-08-30 |
Vertex Pharmaceuticals Incorporated |
Co-crystals comprising vx-950 and pharmaceutical compositions comprising the same
|
CA2646229A1
(en)
|
2006-03-16 |
2007-09-27 |
Vertex Pharmaceuticals Incorporated |
Deuterated hepatitis c protease inhibitors
|
US8017612B2
(en)
|
2006-04-18 |
2011-09-13 |
Japan Tobacco Inc. |
Piperazine compound and use thereof as a HCV polymerase inhibitor
|
GB0609492D0
(en)
*
|
2006-05-15 |
2006-06-21 |
Angeletti P Ist Richerche Bio |
Therapeutic agents
|
GB0612423D0
(en)
*
|
2006-06-23 |
2006-08-02 |
Angeletti P Ist Richerche Bio |
Therapeutic agents
|
KR20090024834A
(ko)
*
|
2006-07-05 |
2009-03-09 |
인터뮨, 인크. |
C형 간염 바이러스 복제의 신규 억제제
|
EP1886685A1
(en)
|
2006-08-11 |
2008-02-13 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods, uses and compositions for modulating replication of hcv through the farnesoid x receptor (fxr) activation or inhibition
|
MX2009000882A
(es)
|
2006-08-17 |
2009-02-04 |
Boehringer Ingelheim Int |
Inhibidores de la polimerasa virica.
|
JP5345541B2
(ja)
*
|
2006-10-24 |
2013-11-20 |
メルク・シャープ・アンド・ドーム・コーポレーション |
Hcvns3プロテアーゼ阻害剤
|
WO2008051477A2
(en)
|
2006-10-24 |
2008-05-02 |
Merck & Co., Inc. |
Hcv ns3 protease inhibitors
|
CA2667266C
(en)
*
|
2006-10-24 |
2015-11-24 |
Merck & Co., Inc. |
Hcv ns3 protease inhibitors
|
EP2086982B1
(en)
*
|
2006-10-27 |
2018-08-29 |
Merck Sharp & Dohme Corp. |
Hcv ns3 protease inhibitors
|
WO2008057208A2
(en)
*
|
2006-10-27 |
2008-05-15 |
Merck & Co., Inc. |
Hcv ns3 protease inhibitors
|
US8101595B2
(en)
|
2006-12-20 |
2012-01-24 |
Istituto di Ricerche di Biologia Molecolare P. Angletti SpA |
Antiviral indoles
|
GB0625349D0
(en)
|
2006-12-20 |
2007-01-31 |
Angeletti P Ist Richerche Bio |
Therapeutic compounds
|
GB0625345D0
(en)
|
2006-12-20 |
2007-01-31 |
Angeletti P Ist Richerche Bio |
Therapeutic compounds
|
CN101631773A
(zh)
|
2006-12-22 |
2010-01-20 |
先灵公司 |
治疗或预防hcv和相关病毒感染的4,5-环化吲哚衍生物
|
WO2008136815A2
(en)
|
2006-12-22 |
2008-11-13 |
Schering Corporation |
5, 6-ring annulated indole derivatives and use thereof
|
MX2009006878A
(es)
*
|
2006-12-22 |
2009-07-07 |
Schering Corp |
Derivados indolicos con anillo unido en las posiciones 4,5 para tratar o prevenir infecciones virales por virus de la hepatitis c e infecciones virales relacionadas.
|
CN101903392A
(zh)
|
2007-02-27 |
2010-12-01 |
弗特克斯药品有限公司 |
丝氨酸蛋白酶的抑制剂
|
JP2010519330A
(ja)
*
|
2007-02-27 |
2010-06-03 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
共結晶体およびそれを含む医薬組成物
|
CA2686138A1
(en)
*
|
2007-05-03 |
2008-11-13 |
Intermune, Inc. |
Novel macrocyclic inhibitors of hepatitis c virus replication
|
EP2494991A1
(en)
|
2007-05-04 |
2012-09-05 |
Vertex Pharmaceuticals Incorporated |
Combination therapy for the treatment of HCV infection
|
AR066528A1
(es)
|
2007-05-10 |
2009-08-26 |
Array Biopharma Inc |
Peptidos inhibidores de la replicacion del virus de la hepatitis c
|
WO2009010785A1
(en)
|
2007-07-17 |
2009-01-22 |
Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa |
Macrocyclic indole derivatives for the treatment of hepatitis c infections
|
US8927569B2
(en)
|
2007-07-19 |
2015-01-06 |
Merck Sharp & Dohme Corp. |
Macrocyclic compounds as antiviral agents
|
WO2009018657A1
(en)
|
2007-08-03 |
2009-02-12 |
Boehringer Ingelheim International Gmbh |
Viral polymerase inhibitors
|
MX2010002319A
(es)
*
|
2007-08-29 |
2010-03-22 |
Schering Corp |
Derivados indolicos 2,3 sustituidos para el tratamiento de infecciones virales.
|
RU2010111551A
(ru)
|
2007-08-29 |
2011-10-10 |
Шеринг Корпорейшн (US) |
Замещенные индольные производные и способы их применения
|
PE20090994A1
(es)
|
2007-08-29 |
2009-08-03 |
Schering Corp |
Derivados de azaindol 2,3-sustituidos como agentes antivirales
|
CN101835774B
(zh)
|
2007-08-30 |
2014-09-17 |
弗特克斯药品有限公司 |
共晶体和包含该共晶体的药物组合物
|
US8419332B2
(en)
*
|
2007-10-19 |
2013-04-16 |
Atlas Bolt & Screw Company Llc |
Non-dimpling fastener
|
US8383583B2
(en)
|
2007-10-26 |
2013-02-26 |
Enanta Pharmaceuticals, Inc. |
Macrocyclic, pyridazinone-containing hepatitis C serine protease inhibitors
|
MX2010005261A
(es)
|
2007-11-14 |
2010-10-15 |
Enanta Pharm Inc |
Inhibidores macrocíclicos de proteasa de serina de hepatitis c de tetrazolilo.
|
CL2008003384A1
(es)
|
2007-11-14 |
2009-12-11 |
Enanta Pharm Inc |
Compuestos derivados de quinoxalina macrocíclica, inhibidores de serina proteasa; composicion farmaceutica que los comprende; y su uso en el tratamiento de la hepatitis c.
|
MX2010005356A
(es)
*
|
2007-11-16 |
2010-05-27 |
Schering Corp |
Derivados de indol 3-heterociclico sustituidos y metodos de uso de los mismos.
|
WO2009064852A1
(en)
*
|
2007-11-16 |
2009-05-22 |
Schering Corporation |
3-aminosulfonyl substituted indole derivatives and methods of use thereof
|
US8273709B2
(en)
|
2007-12-14 |
2012-09-25 |
Enanta Pharmaceuticals, Inc. |
Triazole-containing macrocyclic HCV serine protease inhibitors
|
JP2011506472A
(ja)
|
2007-12-14 |
2011-03-03 |
エナンタ ファーマシューティカルズ インコーポレイテッド |
大環状オキシミルc型肝炎セリンプロテアーゼ阻害剤
|
KR20100098534A
(ko)
|
2007-12-19 |
2010-09-07 |
베링거 인겔하임 인터내셔날 게엠베하 |
바이러스 폴리머라제 억제제
|
KR100967989B1
(ko)
*
|
2008-01-16 |
2010-07-07 |
연세대학교 산학협력단 |
구조변경이 가능한 전환형 휠체어
|
RU2490272C2
(ru)
*
|
2008-02-04 |
2013-08-20 |
Айденикс Фармасьютикалз, Инк. |
Макроциклические ингибиторы серинпротеазы
|
US8591878B2
(en)
|
2008-02-25 |
2013-11-26 |
Merck Sharp & Dohme Corp. |
Therapeutic compounds
|
CN102015652A
(zh)
|
2008-03-20 |
2011-04-13 |
益安药业 |
作为丙型肝炎病毒抑制剂的氟化大环化合物
|
CN102046622A
(zh)
*
|
2008-04-15 |
2011-05-04 |
因特蒙公司 |
丙型肝炎病毒复制的新颖大环抑制剂
|
US8461107B2
(en)
|
2008-04-28 |
2013-06-11 |
Merck Sharp & Dohme Corp. |
HCV NS3 protease inhibitors
|
WO2009152200A1
(en)
*
|
2008-06-13 |
2009-12-17 |
Schering Corporation |
Tricyclic indole derivatives and methods of use thereof
|
SI2540350T1
(sl)
|
2008-07-22 |
2015-01-30 |
Merck Sharp & Dohme Corp. |
Kombinacije makrocikliäśnih kinoksalinske spojine, ki je hcv ns3 proteazni inhibitor z drugimi hcv uäśinkovinami
|
JP5731976B2
(ja)
|
2008-08-20 |
2015-06-10 |
メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. |
置換ピリジン誘導体および置換ピリミジン誘導体ならびにそれらのウイルス感染の治療における使用
|
AR072939A1
(es)
|
2008-08-20 |
2010-09-29 |
Schering Corp |
Derivados de piridina y pirimidina sustituidas con etenilo y su uso en el tratamiento de infecciones virales
|
JP5654990B2
(ja)
|
2008-08-20 |
2015-01-14 |
メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. |
アゾ置換ピリジンおよびピリミジン誘導体ならびにそれらのウイルス感染の治療における使用
|
JP5674661B2
(ja)
|
2008-08-20 |
2015-02-25 |
メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. |
エチニル置換ピリジンおよびピリミジン誘導体ならびにそれらのウイルス感染の治療における使用
|
SG172848A1
(en)
|
2009-01-07 |
2011-08-29 |
Scynexis Inc |
Cyclosporine derivative for use in the treatment of hcv and hiv infection
|
US8102720B2
(en)
*
|
2009-02-02 |
2012-01-24 |
Qualcomm Incorporated |
System and method of pulse generation
|
AR075584A1
(es)
*
|
2009-02-27 |
2011-04-20 |
Intermune Inc |
COMPOSICIONES TERAPEUTICAS QUE COMPRENDEN beta-D-2'-DESOXI-2'-FLUORO-2'-C-METILCITIDINA Y UN DERIVADO DE ACIDO ISOINDOL CARBOXILICO Y SUS USOS. COMPUESTO.
|
WO2010101967A2
(en)
|
2009-03-04 |
2010-09-10 |
Idenix Pharmaceuticals, Inc. |
Phosphothiophene and phosphothiazole hcv polymerase inhibitors
|
US8377962B2
(en)
|
2009-04-08 |
2013-02-19 |
Idenix Pharmaceuticals, Inc. |
Macrocyclic serine protease inhibitors
|
CN102458444A
(zh)
*
|
2009-05-13 |
2012-05-16 |
英安塔制药有限公司 |
用作丙型肝炎病毒抑制剂的大环化合物
|
US8980920B2
(en)
|
2009-05-29 |
2015-03-17 |
Merck Sharp & Dohme Corp. |
Antiviral compounds of three linked aryl moieties to treat diseases such as hepatitis C
|
US8937150B2
(en)
|
2009-06-11 |
2015-01-20 |
Abbvie Inc. |
Anti-viral compounds
|
ES2565536T3
(es)
*
|
2009-06-11 |
2016-04-05 |
Abbvie Bahamas Ltd. |
Heterociclos trisustituidos como inhibidores de la replicación del virus de la Hepatitis C VHC
|
US8828930B2
(en)
|
2009-07-30 |
2014-09-09 |
Merck Sharp & Dohme Corp. |
Hepatitis C virus NS3 protease inhibitors
|
AU2009350857A1
(en)
*
|
2009-08-05 |
2012-02-02 |
Polyphor Ag |
Conformationally constrained, fully synthetic macrocyclic compounds
|
US9284307B2
(en)
|
2009-08-05 |
2016-03-15 |
Idenix Pharmaceuticals Llc |
Macrocyclic serine protease inhibitors
|
EA201290128A1
(ru)
*
|
2009-09-28 |
2013-01-30 |
Интермьюн, Инк. |
Новые макроциклические ингибиторы репликации вируса гепатита с
|
WO2011063076A1
(en)
|
2009-11-19 |
2011-05-26 |
Itherx Pharmaceuticals, Inc. |
Methods of treating hepatitis c virus with oxoacetamide compounds
|
US20120276047A1
(en)
|
2009-11-25 |
2012-11-01 |
Rosenblum Stuart B |
Fused tricyclic compounds and derivatives thereof useful for the treatment of viral diseases
|
MY159958A
(en)
|
2009-12-18 |
2017-02-15 |
Idenix Pharmaceuticals Inc |
5,5-fused arylene or heteroarylene hepatitis c virus inhibitors
|
JP2013515068A
(ja)
|
2009-12-22 |
2013-05-02 |
メルク・シャープ・アンド・ドーム・コーポレーション |
ウイルス性疾患の治療のための縮合三環式化合物およびその使用方法
|
EP2536410B1
(en)
|
2010-02-18 |
2015-09-23 |
Merck Sharp & Dohme Corp. |
Substituted pyrimidine derivatives and their use in treating viral infections
|
MX2012010392A
(es)
|
2010-03-09 |
2012-10-03 |
Merck Sharp & Dohme |
Compuesto de sililo triciclicos fusionados y metodos de uso de los mismos para el tratamiento de enfermedades virales.
|
NZ605440A
(en)
|
2010-06-10 |
2014-05-30 |
Abbvie Bahamas Ltd |
Solid compositions comprising an hcv inhibitor
|
US20140377223A1
(en)
|
2010-07-26 |
2014-12-25 |
Joseph A. Kozlowski |
Substituted biphenylene compounds and methods of use thereof for the treatment of viral diseases
|
BR112013006693B1
(pt)
|
2010-09-21 |
2022-07-12 |
Enanta Pharmaceuticals, Inc |
Compostos inibidores da serino protease hcv derivada de prolina macrocíclica
|
AU2011314168A1
(en)
|
2010-09-29 |
2013-04-04 |
Merck Sharp & Dohme Corp. |
Fused tetracycle derivatives and methods of use thereof for the treatment of viral diseases
|
US9353100B2
(en)
|
2011-02-10 |
2016-05-31 |
Idenix Pharmaceuticals Llc |
Macrocyclic serine protease inhibitors, pharmaceutical compositions thereof, and their use for treating HCV infections
|
WO2012107589A1
(en)
|
2011-02-11 |
2012-08-16 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and pharmaceutical compositions for the treatment and prevention of hcv infections
|
US20120252721A1
(en)
|
2011-03-31 |
2012-10-04 |
Idenix Pharmaceuticals, Inc. |
Methods for treating drug-resistant hepatitis c virus infection with a 5,5-fused arylene or heteroarylene hepatitis c virus inhibitor
|
CN103582420B
(zh)
|
2011-04-13 |
2016-10-19 |
默沙东公司 |
2’-取代的核苷衍生物和使用其治疗病毒病的方法
|
US9156872B2
(en)
|
2011-04-13 |
2015-10-13 |
Merck Sharp & Dohme Corp. |
2′-azido substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
|
US10201584B1
(en)
|
2011-05-17 |
2019-02-12 |
Abbvie Inc. |
Compositions and methods for treating HCV
|
WO2013033900A1
(en)
|
2011-09-08 |
2013-03-14 |
Merck Sharp & Dohme Corp. |
Tetracyclic heterocycle compounds and methods of use thereof for the treatment of viral diseases
|
WO2013033899A1
(en)
|
2011-09-08 |
2013-03-14 |
Merck Sharp & Dohme Corp. |
Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseases
|
WO2013033901A1
(en)
|
2011-09-08 |
2013-03-14 |
Merck Sharp & Dohme Corp. |
Heterocyclic-substituted benzofuran derivatives and methods of use thereof for the treatment of viral diseases
|
EP2755981A4
(en)
|
2011-09-14 |
2015-03-25 |
Merck Sharp & Dohme |
HETEROCYCLIC COMPOUNDS CONTAINING SILYL AND METHODS OF USING THE SAME FOR TREATING VIRAL DISEASES
|
US9034832B2
(en)
|
2011-12-29 |
2015-05-19 |
Abbvie Inc. |
Solid compositions
|
US11484534B2
(en)
|
2013-03-14 |
2022-11-01 |
Abbvie Inc. |
Methods for treating HCV
|
US10051347B2
(en)
|
2013-08-02 |
2018-08-14 |
Stephen Hollis |
Displacement sensor
|
EP3046924A1
(en)
|
2013-09-20 |
2016-07-27 |
IDENIX Pharmaceuticals, Inc. |
Hepatitis c virus inhibitors
|
WO2015065817A1
(en)
|
2013-10-30 |
2015-05-07 |
Merck Sharp & Dohme Corp. |
Pseudopolymorphs of an hcv ns5a inhibitor and uses thereof
|
WO2015103490A1
(en)
|
2014-01-03 |
2015-07-09 |
Abbvie, Inc. |
Solid antiviral dosage forms
|
US20170135990A1
(en)
|
2014-03-05 |
2017-05-18 |
Idenix Pharmaceuticals Llc |
Pharmaceutical compositions comprising a 5,5-fused heteroarylene flaviviridae inhibitor and their use for treating or preventing flaviviridae infection
|
WO2015134560A1
(en)
|
2014-03-05 |
2015-09-11 |
Idenix Pharmaceuticals, Inc. |
Solid forms of a flaviviridae virus inhibitor compound and salts thereof
|
JP2015155430A
(ja)
*
|
2015-04-02 |
2015-08-27 |
ポリフォー・アクチェンゲゼルシャフトPolyphor Ag |
コンホメーションを固定された、合成マクロ環化合物
|
JP2017160247A
(ja)
*
|
2017-05-10 |
2017-09-14 |
ポリフォー・アクチェンゲゼルシャフトPolyphor Ag |
コンホメーションを固定された、合成マクロ環化合物
|
US11267809B2
(en)
|
2017-09-14 |
2022-03-08 |
The Board Of Trustees Of The Leland Stanford Junior University |
BAF complex modulating compounds and methods of using the same
|
EP3820460A1
(en)
*
|
2018-07-12 |
2021-05-19 |
The Board of Trustees of the Leland Stanford Junior University |
Methods for reversing hiv latency using baf complex modulating compounds
|
CN113387842A
(zh)
*
|
2021-07-08 |
2021-09-14 |
成都泰和伟业生物科技有限公司 |
一种通过OTf胺化合成芳香伯胺的方法
|